Patents Assigned to Terragen Diversity Inc.
  • Publication number: 20020127659
    Abstract: Degenerate primers which hybridize with various classes of antibiotic biosynthesis genes were used to amplify fragments of DNA from soil and lichen extracts. Cloning and sequencing of the amplified products showed that these products included a variety of novel and previously uncharacterized antibiotic biosynthesis gene sequences, the products of which have the potential to be active as antibiotics, immunosuppressors, antitumor agents, etc.
    Type: Application
    Filed: August 8, 2001
    Publication date: September 12, 2002
    Applicant: Terragen Diversity, Inc.
    Inventors: Barbara Kathleen Waters, Vivian P.W. Miao, Yap Wai Ho, Seow Kah Tong
  • Patent number: 6441148
    Abstract: Xylanase DNA is recovered from soil by PCR amplification using degenerate primers. Because of the complexity of the soil samples, it is likely that the recovered product will include more than one species of polynucleotide. These recovered copies may be cloned into a host organism to produce additional copies of each individual species prior to characterization by sequencing. Recovered DNA which is found to vary from known xylanases can be used in several ways to facilitate production of novel xylanases for industrial application. First, the recovered DNA, or probes corresponding to portions thereof, can be used as a probe to screen DNA libraries and recover intact xylanase genes including the unique regions of the recovered DNA. Second, the recovered DNA or polynucleotides corresponding to portions thereof, can be inserted into a known xylanase gene to produce a recombinant xylanase gene with the sequence variations of the recovered DNA.
    Type: Grant
    Filed: August 6, 1998
    Date of Patent: August 27, 2002
    Assignee: Terragen Diversity, Inc.
    Inventors: Christopher C. A. Radomski, Kah Tong Seow, R. Antony J. Warren, Wai Ho Yap
  • Patent number: 6319898
    Abstract: A number of bacterial cultures were screened for the ability to inhibit sporulation using a strain Streptomyces 85E. Evaluations of the cultures which tested positive in this assay led to the discovery that lipopeptide biosurfactants such as surfactin and viscosin are effective inhibitors of eukaryotic protein kinase activity. Thus, a method for inhibiting eukaryotic protein kinase activity present in a sample or organism includes the step of adding to the sample or organism an effective inhibitory amount of a lipopeptide biosurfactant.
    Type: Grant
    Filed: October 16, 1998
    Date of Patent: November 20, 2001
    Assignee: Terragen Diversity, Inc.
    Inventors: Julian E. Davies, Barbara Waters, Geeta Saxena
  • Patent number: 6297007
    Abstract: Degenerate primers which hybridize with various classes of antibiotic biosynthesis genes were used to amplify fragments of DNA from soil and lichen extracts. Cloning and sequencing of the amplified products showed that these products included a variety of novel and previously uncharacterized antibiotic biosynthesis gene sequences, the products of which have the potential to be active as antibiotics, immunosuppressors, antitumor agents, etc.
    Type: Grant
    Filed: May 22, 1997
    Date of Patent: October 2, 2001
    Assignee: Terragen Diversity Inc.
    Inventors: Barbara Waters, Vivian Miao, Yap Wai Ho, Seow Kah Tong
  • Patent number: 5849491
    Abstract: Xylanase DNA is recovered from soil by PCR amplification using degenerate primers. Because of the complexity of the soil samples, it is likely that the recovered product will include more than one species of polynucleotide. These recovered copies may be cloned into a host organism to produce additional copies of each individual species prior to characterization by sequencing. Recovered DNA which is found to vary from known xylanases can be used in several ways to facilitate production of novel xylanases for industrial application. First, the recovered DNA, or probes corresponding to portions thereof, can be used as a probe to screen DNA libraries and recover intact xylanase genes including the unique regions of the recovered DNA. Second, the recovered DNA or polynucleotides corresponding to portions thereof, can be inserted into a known xylanase gene to produce a recombinant xylanase gene with the sequence variations of the recovered DNA.
    Type: Grant
    Filed: September 20, 1996
    Date of Patent: December 15, 1998
    Assignee: Terragen Diversity Inc.
    Inventors: Christopher C. A. Radomski, Kah Tong Seow, R. Antony J. Warren, Wai Ho Yap
  • Patent number: 5770392
    Abstract: Materials can be assayed for activity as an inhibitor of post-translational protein phosphorylation by adding the material to a growing culture of a prokaryotic organism such as a streptomycete; allowing the culture to grow for a period of time in the presence of the material; and observing the culture for altered development relative to development of the prokaryotic organism grown in the absence of the material. Observation of altered development is indicative that the material has activity as an inhibitor of post-translational protein phosphorylation. In particular, the material to be tested can be added to a growing culture of the prokaryotic organism by placing a carrier disk bearing the material on a freshly seeded plate. Inhibition of the development of aerial mycelia and spore formation is an indicator that the material has activity as an inhibitor of post-translational protein phosphorylation.
    Type: Grant
    Filed: October 17, 1996
    Date of Patent: June 23, 1998
    Assignee: TerraGen Diversity Inc.
    Inventors: Julian E. Davies, Barbara Waters